Abstract
(3H)Buspirone binds with high affinity (KD = 11 nM) to sections from rat striatum. Spiroperidol, chlorpromazine, (+)-butaclamol and apomorphine are the most potent inhibitors of (3H)buspirone binding. Ketanserin, SCH 23390, serotonin and phentolamine are clearly less active. The regional distribution of (3H)buspirone binding in rat and marmoset brain is characterized by high silver grain densities in the olfactory tubercle, nucleus accumbens and striatum. In the hypophysis, the pars intermedia is strongly labeled. Within the hippocampal formation, slightly higher binding site densities are found in the dentate gyrus. The distribution pattern of binding sites in the dentate gyrus varies according to the species investigated. The data presented in this study permit the conclusion that (3H)buspirone binds with high affinity to dopamine 2 receptors but do not exclude additional binding to other types of receptors, e.g. 5-HT1 receptors. The interaction of buspirone with dopamine 2 receptors may be mainly responsible for its pharmacological profile.
References
Jun 1, 1979·The Journal of Pharmacy and Pharmacology·A TheodorouC D Marsden
Oct 5, 1978·Nature·N R Zahniser, P B Molinoff
Apr 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·B A McMillenM K Sanghera
Feb 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·W U DompertJ Traber
Sep 1, 1985·Biological Psychiatry·S J Peroutka
Dec 9, 1985·Brain Research·T GlaserA Schleicher
Mar 1, 1986·Pharmacology, Biochemistry, and Behavior·S Pellow, S E File
Jan 1, 1986·Psychopharmacology·T F Meert, F C Colpaert
Oct 1, 1986·Journal of Neuroscience Methods·K ZillesJ Traber
Jan 1, 1987·Neuroscience·M L BouthenetJ C Schwartz
Dec 29, 1987·Neuroscience Letters·G BrüningH G Baumgarten
Mar 15, 1988·European Journal of Pharmacology·G Bianchi, S Garattini
Nov 1, 1985·British Journal of Pharmacology·P SkolnickM B Youdim
Feb 26, 1986·Brain Research·P KaulenH G Baumgarten
Nov 1, 1985·Journal of Pharmacological Methods·G A McPherson
Jan 21, 1985·Neuroscience Letters·P KaulenH G Baumgarten
Mar 18, 1983·European Journal of Pharmacology·T Glaser, J Traber
Jul 18, 1983·Life Sciences·P L WoodP Etienne
Dec 1, 1983·Neuropharmacology·M E GoldbergJ B Malick
Jan 1, 1984·Psychopathology·L A RibletC P VanderMaelen
Aug 20, 1984·Brain Research·R B RothmanM A Cascieri
Sep 8, 1983·Nature·H GozlanM Hamon
Jul 30, 1984·Brain Research·R C MeibachJ P Green
Nov 1, 1984·Neuroscience·C Köhler
Dec 12, 1983·Brain Research·P P DeshmukhD L Nelson
Oct 8, 1982·Neuroscience Letters·S L LightmanS P Hunt
Jan 1, 1985·Neurochemistry International·D R Gehlert, J K Wamsley
Citations
Jan 1, 1991·Journal of Neural Transmission. General Section·H S Lee, H Y Meltzer
Apr 19, 1991·Brain Research·H TanakaM Nakamura
Jan 1, 1991·Neurochemistry International·F RadjaM Hamon
Sep 1, 1991·Pharmacology & Toxicology·G Tunnicliff
Jun 1, 1993·Pharmacology & Toxicology·S AhleniusA Wijkström
Nov 24, 2012·The International Journal of Neuropsychopharmacology·Bernard Le Foll, Isabelle Boileau
Jan 1, 1994·Journal of Psychopharmacology·M HascoëtA Coüetoux du Tertre
Jan 1, 1993·Journal of Psychopharmacology·C Pantelis, T R Barnes